admins3d

Despite the complexity of 2020, NORAKER turnover continued to increase. This remarkable results also shows that, despite cancelled elective surgeries, our solutions are much needed to improve patients recovery ! Thank you all for continuing to trust us and for choosing innovative NORAKER solutions!

From June 2020 to February 2021, the construction of our new building, with more than 1500 sqm dedicated to the manufacturing of Bioglass solutions. The validation of controlled environments rooms is in progress, and soon the pleasure of welcoming you!

To always better inform our Partners as well as Healthcare Professionals, our new product documentation are now available. You will discover the ranges of NORAKER medical devices for orthopedic, dental and sports medicine surgeries.

The NORAKER team will be pleased to welcome you to the SFCR congress (booth n° 26)

With conviction and enthusiasm NORAKER is associated with the International Scoliosis Screening Month. Partner of the Academy of French Know-How (ASFF), NORAKER is engaged to support surgeons in the treatment of pediatric scoliosis pathologies.

NORAKER’s expansion continues with the start of the Bioserra 2 site. We are doubling our production area in the Lyon Metropolis to multiply our production capacity by 5

At the end of 2019, NORAKER received support from the European Commission as part of the “SME Instrument Horizon 2020” project. The European contribution consists in the allocation of 2.5m € funding and in the strategic support of the company for a 2 year project. These resources are allocated to help NORAKER to diversify its

In 2019, Noraker had the privilege of benefiting from the Auvergne-Rhône-Alpes Entreprises Agency support. The Auvergne-Rhône-Alpes Entreprises Agency provided support to Naraker in 2 topics: – CE marking: Help to bring Noraker products into compliance with the new regulations relating to the CE medical marking of medical devices. – Industry of the future: 18% subsidy